James Caruso is the founder of Cellectar Biosciences. Cellectar Biosciences has raised $103M in total funding. Latest round: Growth.
James Caruso is the President, CEO, and Director of Cellectar Biosciences, a late-stage clinical biopharmaceutical company focused on developing targeted drugs for cancer treatment. He was appointed to this role in June 2015. Prior to Cellectar Biosciences, he co-founded Hip Innovation Technology, a medical device company where he served as Executive Vice President and Chief Operating Officer. He also held leadership positions at Allos Therapeutics, Inc. and Bone Care International, Inc., both of which were acquired, and worked for multinational pharmaceutical companies like Novartis and Bristol-Myers Squibb.
Full founder directory · Investor directory · Company funding database · Fundraising library